Chouinard Michel 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Dec 1, 2010
Insider Transaction Report
Form 4
Chouinard Michel
COO, Biovail Labs.Int'l SRL
Transactions
- Sale
Common Shares, no par value
2010-11-15$25.16/sh−102,600$2,581,416→ 2,528 total - Exercise/Conversion
Common Shares, no par value
2010-11-29$22.05/sh+32,250$711,113→ 34,720 total - Sale
Common Shares, no par value
2010-11-29$25.30/sh−32,250$815,925→ 2,470 total - Sale
Common Shares, no par value
2010-11-15$25.13/sh−58$1,458→ 2,470 total - Exercise/Conversion
Stock Options (right to purchase)
2010-11-29−32,250→ 0 totalExercise: $22.05From: 2010-03-01Exp: 2012-03-22→ Common Shares, no par value (32,250 underlying)
Footnotes (2)
- [F1]Converted from Cdn. $25.33 using the Bank of Canada exchange rate of $0.9935 (exchange rate on the transaction date)
- [F2]Converted from Cdn. $25.30 using the Bank of Canada exchange rate of $0.9935 (exchange rate on the transaction date).